Search

Your search keyword '"Grunebaum L"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Grunebaum L" Remove constraint Author: "Grunebaum L" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
43 results on '"Grunebaum L"'

Search Results

2. Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement

3. Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement

4. Primary hemostatic disorders drive early and late major bleedings of patients with atrial fibrillation after transcatheter aortic valve replacement

5. Venous thromboembolism in non-critically ill patients with COVID-19 infection

6. Adequate P2Y12 inhibition by clopidogrel increases adverse clinical events in patients undergoing transcatheter aortic valve replacement

7. P2Y12 inhibition by clopidogrel increases adverse clinical outcomes in patients undergoing transcatheter aortic valve replacement

12. 4283Impact of primary hemostasis disorders on late (>30 days) major/life-threatening bleedings after TAVR

14. Impact of CT-ADP point-of-care assay on 30-day paravalvular aortic regurgitation and bleeding events following transcatheter aortic valve replacement

16. French Intensive Care Society, International congress - Réanimation 2016

21. Light on lasers. Off-face photoaging.

23. French Intensive Care Society, International congress – Réanimation 2016

24. A Multicenter, Randomized, Evaluator-Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows.

25. Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters.

26. Baseline mean platelet volume is a strong predictor of major and life-threatening bleedings after transcatheter aortic valve replacement.

27. Cerebral Venous Thrombosis: Clinical, Radiological, Biological, and Etiological Characteristics of a French Prospective Cohort (FPCCVT)-Comparison With ISCVT Cohort.

28. Vaccine-induced immune thrombotic thrombocytopenia: current evidence, potential mechanisms, clinical implications, and future directions.

29. Heparin-induced thrombocytopenia: Construction of a pretest diagnostic score derived from the analysis of a prospective multinational database, with internal validation.

30. Microparticles in COVID-19 as a link between lung injury extension and thrombosis.

31. Acute Pulmonary Embolism in Patients with and without COVID-19.

32. Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study.

33. D-Dimers Level as a Possible Marker of Extravascular Fibrinolysis in COVID-19 Patients.

34. Delayed pulmonary embolism after COVID-19 pneumonia: a case report.

35. Periprocedural Predictors of New-Onset Conduction Abnormalities After Transcatheter Aortic Valve Replacement.

36. COVID-19 Related Coagulopathy: A Distinct Entity?

38. Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement.

39. Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats.

40. Argatroban in the management of heparin-induced thrombocytopenia: a multicenter clinical trial.

41. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension.

42. Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin.

43. Frequent factor II G20210A mutation in idiopathic portal vein thrombosis.

Catalog

Books, media, physical & digital resources